79 related articles for article (PubMed ID: 8073693)
21. Dietary fish oil does not prevent doxorubicin-induced cardiomyopathy in rats.
Matsui H; Morishima I; Hayashi K; Kamiya H; Saburi Y; Okumura K
Can J Cardiol; 2002 Mar; 18(3):279-86. PubMed ID: 11907617
[TBL] [Abstract][Full Text] [Related]
22. Effects of dietary fish oil on lipid peroxidation and serum triacylglycerol levels in psychologically stressed mice.
Oarada M; Tsuzuki T; Gonoi T; Igarashi M; Kamei K; Nikawa T; Hirasaka K; Ogawa T; Miyazawa T; Nakagawa K; Kurita N
Nutrition; 2008 Jan; 24(1):67-75. PubMed ID: 18070659
[TBL] [Abstract][Full Text] [Related]
23. Long-term treatment of N-3 PUFAS on plasma lipoprotein levels and fatty acid composition of total serum and erythrocyte lipids in hypertriglyceridemic patients.
Putadechakum S; Tanphaichitr V; Leelahagul P; Pakpeankitvatana V; Surapisitchart T; Komindr S
J Med Assoc Thai; 2005 Feb; 88(2):181-6. PubMed ID: 15962668
[TBL] [Abstract][Full Text] [Related]
24. [Omega-3 fatty acids, fish, fish oil and cardiovascular disease--a review with implications to Israeli nutritional guidelines].
Eilat-Adar S; Lipovetzky N; Goldbourt U; Henkin Y
Harefuah; 2004 Aug; 143(8):585-91, 622, 621. PubMed ID: 15523812
[TBL] [Abstract][Full Text] [Related]
25. Omega-3 fatty acid containing diets decrease plasma triglyceride concentrations in mice by reducing endogenous triglyceride synthesis and enhancing the blood clearance of triglyceride-rich particles.
Qi K; Fan C; Jiang J; Zhu H; Jiao H; Meng Q; Deckelbaum RJ
Clin Nutr; 2008 Jun; 27(3):424-30. PubMed ID: 18362042
[TBL] [Abstract][Full Text] [Related]
26. Control of salicylate intolerance with fish oils.
Healy E; Newell L; Howarth P; Friedmann PS
Br J Dermatol; 2008 Dec; 159(6):1368-9. PubMed ID: 18795922
[TBL] [Abstract][Full Text] [Related]
27. [The antiatherogenic action of plant oils with added omega-3 polyunsaturated fatty acids].
Kochetova MM; Eremina IV; Kliuchnikova ZhI; Solov'eva EF; Butusova NN; Torkhovskaia TI; Khalilov EM
Biull Eksp Biol Med; 1993 Oct; 116(10):407-9. PubMed ID: 8117967
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of dietary supplementation with fish oil or soy lecithin on human platelet adhesion.
Andrioli G; Carletto A; Guarini P; Galvani S; Biasi D; Bellavite P; Corrocher R
Thromb Haemost; 1999 Nov; 82(5):1522-7. PubMed ID: 10595648
[TBL] [Abstract][Full Text] [Related]
29. [Clinico-biochemical validation of the use of PUFA omega-3 in patients with ischemic heart disease, familial hyperlipoproteinemias and hypertension].
Pogozheva AV; Samsonov MA; Levachev MM
Vopr Pitan; 1996; (1):34-6. PubMed ID: 9157710
[TBL] [Abstract][Full Text] [Related]
30. Marine lipids: overview "news insights and lipid composition of Lyprinol".
Sinclair AJ; Murphy KJ; Li D
Allerg Immunol (Paris); 2000 Sep; 32(7):261-71. PubMed ID: 11094639
[TBL] [Abstract][Full Text] [Related]
31. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake.
Leaf A; Albert CM; Josephson M; Steinhaus D; Kluger J; Kang JX; Cox B; Zhang H; Schoenfeld D;
Circulation; 2005 Nov; 112(18):2762-8. PubMed ID: 16267249
[TBL] [Abstract][Full Text] [Related]
32. Vitamin E increases the risk of developing heart failure after myocardial infarction: Results from the GISSI-Prevenzione trial.
Marchioli R; Levantesi G; Macchia A; Marfisi RM; Nicolosi GL; Tavazzi L; Tognoni G; Valagussa F;
J Cardiovasc Med (Hagerstown); 2006 May; 7(5):347-50. PubMed ID: 16645413
[TBL] [Abstract][Full Text] [Related]
33. Effect of fish oil on offensive and defensive factors in gastric ulceration in rats.
Bhattacharya A; Ghosal S; Bhattacharya SK
Prostaglandins Leukot Essent Fatty Acids; 2006 Feb; 74(2):109-16. PubMed ID: 16352428
[TBL] [Abstract][Full Text] [Related]
34. Omega-3 fatty acid supplementation stimulates alpha-tocopherol incorporation in erythrocyte membranes in adult men.
Berlin E; Bhathena SJ; Judd JT; Nair PP; Peters RC; Bhagavan HN; Ballard-Barbash R; Taylor PR
Ann N Y Acad Sci; 1992 Sep; 669():322-4. PubMed ID: 1444038
[No Abstract] [Full Text] [Related]
35. Diagnosis, screening and follow-up of gastrointestinal cancer.
Zfass AM
Med Sect Proc; 1987; ():77-91. PubMed ID: 3452832
[No Abstract] [Full Text] [Related]
36. GISSI-Prevenzione trial.
Hopper L; Ness A; Higgins JP; Moore T; Ebrahim S
Lancet; 1999 Oct; 354(9189):1557. PubMed ID: 10551523
[No Abstract] [Full Text] [Related]
37. Lipid treatment in inflammatory bowel disease.
Belluzzi A
Nestle Nutr Workshop Ser Clin Perform Programme; 1999; 2():199-211; discussion 211-5. PubMed ID: 11490623
[No Abstract] [Full Text] [Related]
38. Improving outcomes in gastrointestinal cancer.
Alderson D; Winter DC
Br J Surg; 2013 Jan; 100(1):1-2. PubMed ID: 23169474
[No Abstract] [Full Text] [Related]
39. [Tumor prevention in gastroenterology].
Matek W; Demling L
Fortschr Med; 1985 Dec; 103(47-48):1081-3. PubMed ID: 4085951
[No Abstract] [Full Text] [Related]
40. Antioxidant supplements for prevention of gastrointestinal cancers.
Correa P; Fontham E; Bravo LE; Mera R
Lancet; 2005 Feb 5-11; 365(9458):470; author reply 471-2. PubMed ID: 15705450
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
